Ambry Starts Rare Disease Study - Orange County Business Journal

Genetic testing firm Ambry Genetics and Pacific Biosciences of California Inc. are working together to find the genetic cause of rare diseases in pediatric patients.PacBio (Nasdaq: PACB), a biotechnology company in Menlo Park valued at $524 million, manufactures gene sequencing technology for scientists and clinical researchers.

Related Keywords

Aliso ,California ,United States ,Orange County ,Menlo Park ,Irvine ,Charles Dunlop ,Tom Schoenherr ,Pacific Biosciences ,National Institutes Of Health ,Konica Minolta ,California Inc ,Invitae Corp ,Konica Minolta Inc ,Realm Idx Inc ,Reuters ,University Of California ,Ambry Genetics ,Genomics Research ,Rare Diseases ,National Institutes ,Viejo Based Ambry ,Ambry Chief Executive Tom ,Smith Lemli Opitz Syndrome ,Exome Reveal ,San Francisco Based ,Tokyo Based Konica Minolta ,Business Journal ,Konica Minolta Precision Medicine ,